Targeted Delivery of RNAi Therapeutics With Endogenous and Exogenous Ligand-Based Mechanisms

Cited by (1,002)

Items 201–300 of 1,002

1. In vivo CAR engineering for immunotherapy
   Yan-Ruide Li, Yichen Zhu, Tyler Halladay, Lili Yang · 2025 · Nature reviews. Immunology
2. Specific Endothelial Cells Govern Nanoparticle Entry into Solid Tumors
   Benjamin R. Kingston, Zachary Pengju Lin, Ben Ouyang, Presley MacMillan, Jessica Ngai, Abdullah M. Syed, Shrey Sindhwani, Warren C. W. Chan · 2021 · ACS Nano
3. Lipid Nanoparticles Optimized for Targeting and Release of Nucleic Acid
   Yaru Jia, Xiu‐Guang Wang, Luwei Li, Fangzhou Li, Jinchao Zhang, Xing‐Jie Liang · 2023 · Advanced Materials
4. Ionizable Amino‐Polyesters Synthesized via Ring Opening Polymerization of Tertiary Amino‐Alcohols for Tissue Selective mRNA Delivery
   Piotr S. Kowalski, Umberto Capasso Palmiero, Yuxuan Huang, Arnab Rudra, Róbert Langer, Daniel G. Anderson · 2018 · Advanced Materials
5. Nanoparticles for nucleic acid delivery: Applications in cancer immunotherapy
   Alvin J. Mukalel, Rachel Riley, Rui Zhang, Michael J. Mitchell · 2019 · Cancer Letters
6. Bone-marrow-homing lipid nanoparticles for genome editing in diseased and malignant haematopoietic stem cells
   Xizhen Lian, Sumanta Chatterjee, Yehui Sun, Sean A. Dilliard, Stephen Moore, Yufen Xiao, Xiaoyan Bian, Kohki Yamada, Yun‐Chieh Sung, Rachel M. Levine et al. · 2024 · Nature Nanotechnology
7. Placenta-tropic VEGF mRNA lipid nanoparticles ameliorate murine pre-eclampsia
   Swingle, Kelsey L., Hamilton, Alex G., Safford, Hannah C., Geisler, Hannah C., Thatte, Ajay S., Palanki, Rohan, Murray, Amanda M., Han, Emily L., Mukalel, Alvin J., Han, Xuexiang et al. · 2025 · Nature
8. Systemic RNAi-mediated Gene Silencing in Nonhuman Primate and Rodent Myeloid Cells
   Tatiana I. Novobrantseva, Anna Borodovsky, Jamie Wong, Boris Klebanov, Mohammad R. Zafari, Kristina Yucius, William Querbes, Pei Ge, Vera M. Ruda, Stuart Milstein et al. · 2012 · Molecular Therapy — Nucleic Acids
9. The Scavenger Function of Liver Sinusoidal Endothelial Cells in Health and Disease
   Sabin Bhandari, Anett Kristin Larsen, Peter McCourt, Bård H. Smedsrød, Karen Kristine Sørensen · 2021 · Frontiers in Physiology
10. An RNA Alternative to Human Transferrin: A New Tool for Targeting Human Cells
    Samantha E. Wilner, Brian C. Wengerter, Keith E. Maier, Maria de Lourdes Borba Magalhães, David Soriano del Amo, Supriya Pai, Felipe Opazo, Silvio O. Rizzoli, Amy C. Yan, Matthew Levy · 2012 · Molecular Therapy — Nucleic Acids
11. The role of apolipoprotein- and vitronectin-enriched protein corona on lipid nanoparticles for in vivo targeted delivery and transfection of oligonucleotides in murine tumor models
    Dongyu Chen, Neha N. Parayath, Shanthi Ganesh, Weimin Wang, Mansoor M. Amiji · 2019 · Nanoscale
12. Nanomaterials for Therapeutic RNA Delivery
    Xuexiang Han, Michael J. Mitchell, Guangjun Nie · 2020 · Matter
13. Targeting drug delivery in the vascular system: Focus on endothelium
    Patrick M. Glassman, Jacob W. Myerson, Laura T. Ferguson, Raisa Yu. Kiseleva, Vladimir V. Shuvaev, Jacob S. Brenner, Vladimir R. Muzykantov · 2020 · Advanced Drug Delivery Reviews
14. Cellular uptake and intracellular trafficking of oligonucleotides
    Rudy L. Juliano, Kyle A. Carver · 2015 · Advanced Drug Delivery Reviews
15. Interactions at the cell membrane and pathways of internalization of nano-sized materials for nanomedicine
    Valentina Francia, Daphne Montizaan, Anna Laura Salvati · 2020 · Beilstein Journal of Nanotechnology
16. Physiological Barriers and Strategies of Lipid‐Based Nanoparticles for Nucleic Acid Drug Delivery
    Mingdi Hu, Xiaoyan Li, Zhen You, Rong Cai, Chunying Chen · 2023 · Advanced Materials
17. DNA/RNA heteroduplex oligonucleotide for highly efficient gene silencing
    Kazutaka Nishina, Wenying Piao, Kie Yoshida‐Tanaka, Yumiko Sujino, Tomoko Nishina, Tsuyoshi Yamamoto, Keiko Nitta, Kotaro Yoshioka, Hiroya Kuwahara, Hidenori Yasuhara et al. · 2015 · Nature Communications
18. In Vitro–In Vivo Translation of Lipid Nanoparticles for Hepatocellular siRNA Delivery
    Kathryn A. Whitehead, Jonathan Matthews, Philip Chang, Farnaz Niroui, J. Robert Dorkin, Mariano Severgnini, Daniel G. Anderson · 2012 · ACS Nano
19. Direct in vivo CAR T cell engineering
    Lauralie Short, Robert A. Holt, Pieter R. Cullis, Laura Evgin · 2024 · Trends in Pharmacological Sciences
20. Nanoplatforms for mRNA Therapeutics
    Meng, Chaoyang, Chen, Zhe, Li, Gang, Welte, Thomas, Shen, Haifa · 2021 · Advanced Therapeutics
21. Nanoparticle-Based Delivery of CRISPR/Cas9 Genome-Editing Therapeutics
    Brittany E. Givens, Youssef Wahib Naguib, Sean M. Geary, Eric Jeffrey Devor, Aliasger K. Salem · 2018 · The AAPS Journal
22. Protein corona formed on lipid nanoparticles compromises delivery efficiency of mRNA cargo
    Elizabeth Voke, Mariah Lynn Arral, Henry John Squire, Teng-Jui Lin, Lining Zheng, Roxana Coreas, Alison Lui, Anthony T. Iavarone, Rebecca L. Pinals, Kathryn A. Whitehead et al. · 2025 · Nature Communications
23. Preclinical development of a subcutaneous ALAS1 RNAi therapeutic for treatment of hepatic porphyrias using circulating RNA quantification
    Chan, Amy, Liebow, Abigail, Yasuda, Makiko, Gan, Lin, Racie, Tim, Maier, Martin, Kuchimanchi, Satya, Foster, Don, Milstein, Stuart, Charisse, Klaus et al. · 2015 · Molecular Therapy — Nucleic Acids
24. Iterative Design of Ionizable Lipids for Intramuscular mRNA Delivery
    Grayson Tilstra, Julien Couture‐Senécal, Yan Ming Anson Lau, Alanna M. Manning, D. Wong, Wanda W. Janaeska, Titobioluwa A. Wuraola, Janice Pang, Omar F. Khan · 2023 · Journal of the American Chemical Society
25. Optimizing Lipid Nanoparticles for Delivery in Primates
    Kieu Lam, Petra Schreiner, Ada Leung, Paul Stainton, Steve Reid, Ed Yaworski, Peter Lutwyche, James A. Heyes · 2023 · Advanced Materials
26. Understanding nanoparticle-liver interactions in nanomedicine
    Yuxin He, Yifan Wang, Lin Wang, Wen Jiang, Stefan Wilhelm · 2024 · Expert Opinion on Drug Delivery
27. Improving dendritic cell vaccine immunogenicity by silencing PD-1 ligands using siRNA-lipid nanoparticles combined with antigen mRNA electroporation
    Willemijn A. Hobo, Tatiana I. Novobrantseva, Hanny Fredrix, Jamie Wong, Stuart Milstein, Hila Epstein-Barash, Ju Liu, Nicolaas PM Schaap, Robbert van der Voort, Harry Dolstra · 2012 · Cancer Immunology Immunotherapy
28. Safety profile of RNAi nanomedicines
    Scott A. Barros, Jared Gollob · 2012 · Advanced Drug Delivery Reviews
29. Self-degradable lipid-like materials based on “hydrolysis accelerated by the intra-particle enrichment of reactant (HyPER)” for messenger RNA delivery
    Tanaka, Hiroki, Takahashi, Tatsunari, Konishi, Manami, Takata, Nae, Gomi, Masaki, Shirane, Daiki, Miyama, Ryo, Hagiwara, Shinya, Yamasaki, Yuki, Sakurai, Yu et al. · 2020 · Advanced Functional Materials
30. Mild Innate Immune Activation Overrides Efficient Nanoparticle‐Mediated RNA Delivery
    Lokugamage, Melissa P., Gan, Zubao, Zurla, Chiara, Levin, Joel, Islam, Fatima Z., Kalathoor, Sujay, Sato, Manaka, Sago, Cory D., Santangelo, Philip J., Dahlman, James E. · 2020 · Advanced Materials
31. Engineering and Identifying Supercharged Proteins for Macromolecule Delivery into Mammalian Cells
    David B. Thompson, James J. Cronican, David R. Liu · 2012 · Methods in enzymology on CD-ROM/Methods in enzymology
32. RNAi-mediated silencing of hepatic Alas1 effectively prevents and treats the induced acute attacks in acute intermittent porphyria mice
    Makiko Yasuda, Lin Gan, Brenden Chen, Senkottuvelan Kadirvel, Chunli Yu, John D. Phillips, Maria I. New, Abigail Liebow, Kevin J. Fitzgerald, William Querbes et al. · 2014 · Proceedings of the National Academy of Sciences
33. Current challenges and future directions for engineering extracellular vesicles for heart, lung, blood and sleep diseases
    Guoping Li, Tianji Chen, James E. Dahlman, Lola Eniola‐Adefeso, Ionita Calin Ghiran, Peter Kurre, Wilbur Aaron Lam, Jennifer K. Lang, Eduardo Marbán, Pilar Martı́n et al. · 2023 · Journal of Extracellular Vesicles
34. Well-Defined Multivalent Ligands for Hepatocytes Targeting via Asialoglycoprotein Receptor
    Xiangang Huang, Jean‐Christophe Leroux, Bastien Castagner · 2016 · Bioconjugate Chemistry
35. Lipid nanoparticles outperform electroporation in mRNA-based CAR T cell engineering
    Reni Kitte, Martin Rabel, Reka Geczy, Stella Park, Stephan Fricke, Ulrike Koehl, Sandy Tretbar · 2023 · Molecular Therapy — Methods & Clinical Development
36. Endothelial siRNA delivery in nonhuman primates using ionizable low–molecular weight polymeric nanoparticles
    Omar F. Khan, Piotr S. Kowalski, Joshua C. Doloff, Jonathan K. Tsosie, Vasudevan Bakthavatchalu, Caroline Bodi Winn, Jennifer L. Haupt, Morgan Jamiel, Róbert Langer, Daniel G. Anderson · 2018 · Science Advances
37. Dual mRNA co-delivery for in situ generation of phagocytosis-enhanced CAR macrophages augments hepatocellular carcinoma immunotherapy
    Zhenmei Yang, Ying Liu, Kun Zhao, Weiqiang Jing, Lin Gao, Xianghui Dong, Yan Wang, Maosen Han, Chongdeng Shi, Chunwei Tang et al. · 2023 · Journal of Controlled Release
38. Physicochemical Targeting of Lipid Nanoparticles to the Lungs Induces Clotting: Mechanisms and Solutions
    Serena Omo‐Lamai, Marco E. Zamora, Manthan N. Patel, Jichuan Wu, Jia Nong, Zhicheng Wang, Alina D. Peshkova, Aparajeeta Majumder, Jilian R. Melamed, Liam S. Chase et al. · 2024 · Advanced Materials
39. Efficient Hepatic Delivery of Drugs: Novel Strategies and Their Significance
    Nidhi Mishra, Narayan Prasad Yadav, Vineet Kumar, Priyam Sinha, Kuldeep Singh Yadav, Sanyog Jain, Sumit Arora · 2013 · BioMed Research International
40. Extrahepatic targeting of lipid nanoparticles in vivo with intracellular targeting for future nanomedicines
    Nakamura, Takashi, Sato, Yusuke, Yamada, Yuma, Abd Elwakil, Mahmoud M., Kimura, Seigo, Younis, Mahmoud A., Harashima, Hideyoshi · 2022 · Advanced Drug Delivery Reviews
41. Messenger RNA therapy for rare genetic metabolic diseases
    Pedro Berraondo, Paolo G.V. Martini, Matias Antonio Avila, Antonio Fontanellas · 2019 · Gut
42. Evaluation of GalNAc-siRNA Conjugate Activity in Pre-clinical Animal Models with Reduced Asialoglycoprotein Receptor Expression
    Jennifer L. S. Willoughby, Amy Chan, Alfica Sehgal, James S. Butler, Jayaprakash K. Nair, Tim Racie, Svetlana Shulga‐Morskaya, Tuyen M Nguyen, Kun Qian, Kristina Yucius et al. · 2017 · Molecular Therapy
43. Endocytic Profiling of Cancer Cell Models Reveals Critical Factors Influencing LNP-Mediated mRNA Delivery and Protein Expression
    Edward John Sayers, Samantha E. Peel, Anna Schantz, R. England, Maya Beano, Stephanie M. Bates, Arpan S. Desai, Sanyogitta Puri, Marianne B. Ashford, Arwyn Tomos Jones · 2019 · Molecular Therapy
44. Liver as a target for oligonucleotide therapeutics
    Alfica Sehgal, Akshay K. Vaishnaw, Kevin J. Fitzgerald · 2013 · Journal of Hepatology
45. Preclinical evaluation of RNAi as a treatment for transthyretin-mediated amyloidosis
    Butler, James S., Chan, Amy, Costelha, Susete, Fishman, Shannon, Willoughby, Jennifer L. S., Borland, Todd D., Milstein, Stuart, Foster, Donald J., Gonçalves, Paula, Chen, Qingmin et al. · 2016 · Amyloid
46. Mannosylation of LNP Results in Improved Potency for Self-Amplifying RNA (SAM) Vaccines
    Goswami, Roshan, Chatzikleanthous, Despo, Lou, Gustavo, Giusti, Fabiola, Bonci, Alessandra, Taccone, Marianna, Brazzoli, Michela, Gallorini, Simona, Ferlenghi, Ilaria, Berti, Francesco et al. · 2019 · ACS Infectious Diseases
47. mRNA delivery systems for cancer immunotherapy: Lipid nanoparticles and beyond
    Mariona Estapé Sentí, Lucía García del Valle, Raymond Michel Schiffelers · 2024 · Advanced Drug Delivery Reviews
48. Improved Efficacy in a Fabry Disease Model Using a Systemic mRNA Liver Depot System as Compared to Enzyme Replacement Therapy
    DeRosa, Frank, Smith, Lianne, Shen, Yinghua, Huang, Yan, Pan, Jing, Xie, Hongsheng, Yahalom, Barak, Heartlein, Michael W. · 2019 · Molecular Therapy
49. Systemic mRNA delivery to the lungs by functional polyester-based carriers
    Yan, Yunfeng, Xiong, Hu, Zhang, Xinyi, Cheng, Qiang, Siegwart, Daniel J. · 2017 · Biomacromolecules
50. Non-immunotherapy application of LNP-mRNA: Maximizing efficacy and safety
    Vlatkovic, Irena · 2021 · Biomedicines
51. Systemic delivery of mRNA and DNA to the lung using polymer-lipid nanoparticles
    James C. Kaczmarek, Asha Kumari Patel, Luke H. Rhym, Umberto Capasso Palmiero, Balkrishen Bhat, Michael W. Heartlein, Frank DeRosa, Daniel G. Anderson · 2021 · Biomaterials
52. Selective tissue targeting of synthetic nucleic acid drugs
    Punit P. Seth, Michael Tanowitz, C. Frank Bennett · 2019 · Journal of Clinical Investigation
53. Tailoring the lipid composition of nanoparticles modulates their cellular uptake and affects the viability of triple negative breast cancer cells
    Hanan Abumanhal-Masarweh, Dana da Silva, Maria Poley, Assaf Zinger, Evgenya Goldman, Nitzan Krinsky, Ron Kleiner, Gal Shenbach, Josh E. Schroeder, Jeny Shklover et al. · 2019 · Journal of Controlled Release
54. Current landscape of mRNA technologies and delivery systems for new modality therapeutics
    Ruei‐Min Lu, Hsiang-En Hsu, Ser John Lynon P. Perez, Monika Kumari, Guanhong Chen, Ming-Hsiang Hong, Yin-Shiou Lin, Ching-Hang Liu, Shih-Han Ko, Christian Angelo P. Concio et al. · 2024 · Journal of Biomedical Science
55. RNAi-based therapeutic strategies for metabolic disease
    Michael Czech, Myriam Aouadi, Gregory J. Tesz · 2011 · Nature Reviews Endocrinology
56. Different kinetics for the hepatic uptake of lipid nanoparticles between the apolipoprotein E/low density lipoprotein receptor and the N-acetyl-d-galactosamine/asialoglycoprotein receptor pathway
    Yusuke Sato, Yoshiyuki Kinami, Kazuki Hashiba, Hideyoshi Harashima · 2020 · Journal of Controlled Release
57. In vivo cytidine base editing of hepatocytes without detectable off-target mutations in RNA and DNA
    Villiger, Lukas, Rothgangl, Tanja, Witzigmann, Dominik, Oka, Rurika, Lin, Paulo J. C., Qi, Weihong, Janjuha, Sharan, Berk, Christian, Ringnalda, Femke, Beattie, Mitchell B. et al. · 2021 · Nature Biomedical Engineering
58. Recent advances in lipid nanoparticles for delivery of nucleic acid, mRNA, and gene editing-based therapeutics
    Hidefumi Mukai, Koki Ogawa, Naoya Kato, Shigeru Kawakami · 2022 · Drug Metabolism and Pharmacokinetics
59. Effect of PEGylation on Biodistribution and Gene Silencing of siRNA/Lipid Nanoparticle Complexes
    Yanjie Bao, Yi Jin, Padmanabh Chivukula, Jun Zhang, Yun Liu, Jian Liu, Jean‐Pierre Clamme, Ram I. Mahato, Dominic Ng, Wenbin Ying et al. · 2012 · Pharmaceutical Research
60. A Boost for the Emerging Field of RNA Nanotechnology
    Girish C. Shukla, Farzin Haque, Yitzhak Tor, L. Marcus Wilhelmsson, Jean‐Jacques Toulmé, Hervé Isambert, Peixuan Guo, John J. Rossi, Scott A. Tenenbaum, Bruce A. Shapiro · 2011 · ACS Nano
61. The Future of Tissue-Targeted Lipid Nanoparticle-Mediated Nucleic Acid Delivery
    Kularatne, Ruvanthi N., Crist, Rachael M., Stern, Stephan T. · 2022 · Pharmaceuticals
62. Lipid nanocarriers for microRNA delivery
    Marcel Scheideler, Ivan Vidaković, Ruth Prassl · 2019 · Chemistry and Physics of Lipids
63. Can non-viral technologies knockdown the barriers to siRNA delivery and achieve the next generation of cancer therapeutics?
    Jianfeng Guo, Ludovic Bourré, Declan M. Soden, Gerald C. O’Sullivan, Caitríona M. O’Driscoll · 2011 · Biotechnology Advances
64. Highly specific delivery of siRNA to hepatocytes circumvents endothelial cell-mediated lipid nanoparticle-associated toxicity leading to the safe and efficacious decrease in the hepatitis B virus
    Yusuke Sato, Hideki Matsui, Naoki Yamamoto, Risa Sato, Tsubasa Munakata, Michinori Kohara, Hideyoshi Harashima · 2017 · Journal of Controlled Release
65. Nanoparticle single-cell multiomic readouts reveal that cell heterogeneity influences lipid nanoparticle-mediated messenger RNA delivery
    Curtis N. Dobrowolski, Kalina Paunovska, Elisa Schrader Echeverri, David Loughrey, Alejandro J. Da Silva Sanchez, Huanzhen Ni, Marine Z. C. Hatit, Melissa P. Lokugamage, Yanina Kuzminich, Hannah E. Peck et al. · 2022 · Nature Nanotechnology
66. Identifying cell receptors for the nanoparticle protein corona using genome screens
    Wayne Ngo, Jamie L. Y. Wu, Zachary Pengju Lin, Yuwei Zhang, Bram Bussin, Adrian Granda Farias, Abdullah M. Syed, Katherine Chan, Andrea Habsid, Jason Moffat et al. · 2022 · Nature Chemical Biology
67. Modular Design of Biodegradable Ionizable Lipids for Improved mRNA Delivery and Precise Cancer Metastasis Delineation In Vivo
    Zhaoming Chen, Yang Tian, Jieyu Yang, Fapu Wu, Senyao Liu, Wenwen Cao, Weijia Xu, Tao Hu, Daniel J. Siegwart, Hu Xiong · 2023 · Journal of the American Chemical Society
68. Recent Advances in Site-Specific Lipid Nanoparticles for mRNA Delivery
    Xiao Xu, Tian Xia · 2023 · ACS Nanoscience Au
69. Lipid nanoparticle-based strategies for extrahepatic delivery of nucleic acid therapies – challenges and opportunities
    Jens B. Simonsen · 2024 · Journal of Controlled Release
70. Influence of cationic lipid composition on uptake and intracellular processing of lipid nanoparticle formulations of siRNA
    Paulo J.C. Lin, Yuen Yi C. Tam, Ismail M. Hafez, Ammen P. Sandhu, Sam Chen, Marco A. Ciufolini, Ivan R. Nabi, Pieter R. Cullis · 2012 · Nanomedicine Nanotechnology Biology and Medicine
71. Lipid nanoparticle-mediated siRNA delivery for safe targeting of human CML in vivo
    Nidhi Jyotsana, Amit Kumar Sharma, Anuhar Chaturvedi, Ramachandramouli Budida, Michaela Scherr, Florian C. Kuchenbauer, Robert M. Lindner, Fatih Noyan, Kurt‐Wolfram Sühs, Martin Stangel et al. · 2019 · Annals of Hematology
72. Recent developments of RNA-based vaccines in cancer immunotherapy
    Elnaz Faghfuri, Farhad Pourfarzi, Amir Hossein Faghfouri, Mahdi Abdoli Shadbad, Khalil Hajiasgharzadeh, Behzad Baradaran · 2020 · Expert Opinion on Biological Therapy
73. The role of nanoparticle format and route of administration on self-amplifying mRNA vaccine potency
    Giulia Anderluzzi, Gustavo Lou, Stuart Woods, S. Schmidt, Simona Gallorini, Michela Brazzoli, Russell Johnson, Craig W. Roberts, Derek T. O’Hagan, Barbara C. Baudner et al. · 2021 · Journal of Controlled Release
74. Lipid Nanoparticle Technologies for Nucleic Acid Delivery: A Nanoarchitectonics Perspective
    Abdul Rahim Ferhan, Soo-Hyun Park, Hyeonjin Park, Hyunhyuk Tae, Joshua A. Jackman, Nam‐Joon Cho · 2022 · Advanced Functional Materials
75. Delivery of siRNAs to Dendritic Cells Using DEC205-Targeted Lipid Nanoparticles to Inhibit Immune Responses
    Joseph A Katakowski, Gayatri Mukherjee, Samantha E. Wilner, Keith E. Maier, Michael Travis Harrison, Teresa P. DiLorenzo, Matthew Levy, Deborah Palliser · 2015 · Molecular Therapy
76. Review of structural design guiding the development of lipid nanoparticles for nucleic acid delivery
    Marité Cárdenas, Richard A. Campbell, Marianna Yanez Arteta, Margaret Jayne Lawrence, Federica Sebastiani · 2023 · Current Opinion in Colloid & Interface Science
77. Navigating the intricate in-vivo journey of lipid nanoparticles tailored for the targeted delivery of RNA therapeutics: a quality-by-design approach
    Elahe Haghighi, Samira Sadat Abolmaali, Ali Dehshahri, Seyed Ali Mousavi Shaegh, Negar Azarpira, Ali Mohammad Tamaddon · 2024 · Journal of Nanobiotechnology
78. Lipid Nanoparticle Spherical Nucleic Acids for Intracellular DNA and RNA Delivery
    Andrew J. Sinegra, Michael Evangelopoulos, Jungsoo Park, Ziyin N. Huang, Chad Alexander Mirkin · 2021 · Nano Letters
79. Extracellular vesicles versus lipid nanoparticles for the delivery of nucleic acids
    Johannes Bader, Finn Brigger, Jean‐Christophe Leroux · 2024 · Advanced Drug Delivery Reviews
80. A potent epigenetic editor targeting human PCSK9 for durable reduction of low-density lipoprotein cholesterol levels
    Frédéric Tremblay, Qiang Xiong, Shrijal S. Shah, Chih‐Wei Ko, Kenneth Kelly, Mary S. Morrison, Cristiana Giancarlo, Ricardo N. Ramírez, Erica M. Hildebrand, Sarah B. Voytek et al. · 2025 · Nature Medicine
81. Lipid Nanoparticles for Delivery of Therapeutic RNA Oligonucleotides
    Keith Henry Moss, Petya G. Popova, Sine Reker Hadrup, Kira Astakhova, Maria Taskova · 2019 · Molecular Pharmaceutics
82. ‘Passive’ nanoparticles for organ-selective systemic delivery: design, mechanism and perspective
    Liyi Fu, Yang Zhang, Ryan A. Farokhzad, Bárbara B. Mendes, João Conde, Jinjun Shi · 2023 · Chemical Society Reviews
83. Plasma Protein Adsorption and Biological Identity of Systemically Administered Nanoparticles
    Dongyu Chen, Shanthi Ganesh, Weimin Wang, Mansoor M. Amiji · 2017 · Nanomedicine
84. Disposition and Pharmacology of a GalNAc3-conjugated ASO Targeting Human Lipoprotein (a) in Mice
    Rosie Z. Yu, Mark J Graham, Noah M. Post, Stan Riney, Thomas A. Zanardi, Shannon Hall, Jennifer Burkey, Colby S. Shemesh, Thazha P. Prakash, Punit P. Seth et al. · 2016 · Molecular Therapy — Nucleic Acids
85. Targeting RNA With Antisense Oligonucleotides and Small Interfering RNA in Dyslipidemias
    Katzmann, Julius L., Packard, Chris J., Chapman, M. John, Katzmann, Isabell, Laufs, Ulrich · 2020 · Journal of the American College of Cardiology
86. Control of hepatocyte proliferation and survival by Fgf receptors is essential for liver regeneration in mice
    Susagna Padrissa‐Altés, Marc Bachofner, Roman L. Bogorad, Lea Maria Pohlmeier, Thomas Rossolini, Friederike Böhm, Gerhard Liebisch, Claus Hellerbrand, Victor Koteliansky, Tobias Speicher et al. · 2014 · Gut
87. On the size-regulation of RNA-loaded lipid nanoparticles synthesized by microfluidic device
    Kento Okuda, Yusuke Sato, Kazuki Iwakawa, Kosuke Sasaki, Nana Okabe, Masatoshi Maeki, Manabu Tokeshi, Hideyoshi Harashima · 2022 · Journal of Controlled Release
88. Non-viral Delivery of Zinc Finger Nuclease mRNA Enables Highly Efficient In Vivo Genome Editing of Multiple Therapeutic Gene Targets
    Conway, Anthony, Mendel, Matthew, Kim, Kenneth, McGovern, Kyle, Boyko, Alisa, Zhang, Lei, Miller, Jeffrey C., DeKelver, Russell C., Paschon, David E., Mui, Barbara L. et al. · 2019 · Molecular Therapy
89. High-throughput screening identifies small molecules that enhance the pharmacological effects of oligonucleotides
    Bing Yang, Xin Ming, Canhong Cao, Brian M. Laing, Ahu Yuan, Melissa A. Porter, Emily A. Hull-Ryde, Joseph A. Maddry, Mark J. Suto, William P. Janzen et al. · 2015 · Nucleic Acids Research
90. Impact of the protein corona on nanomaterial immune response and targeting ability
    Luca Digiacomo, Daniela Pozzi, Sara Palchetti, Alessandra Zingoni, Giulio Caracciolo · 2020 · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology
91. Thermostable ionizable lipid-like nanoparticle (iLAND) for RNAi treatment of hyperlipidemia
    Bo Hu, Bo Li, Kun Li, Yuanyuan Liu, Chunhui Li, Lulu Zheng, Mengjie Zhang, Tongren Yang, Shuai Guo, Xiyu Dong et al. · 2022 · Science Advances
92. Analysis of PEG-lipid anchor length on lipid nanoparticle pharmacokinetics and activity in a mouse model of traumatic brain injury
    Lauren E. Waggoner, Katelyn F. Miyasaki, Ester J. Kwon · 2023 · Biomaterials Science
93. Influence of polyethylene glycol density and surface lipid on pharmacokinetics and biodistribution of lipid-calcium-phosphate nanoparticles
    Yang Liu, Yunxia Hu, Leaf Huang · 2014 · Biomaterials
94. Nanomedicines inhibiting tumor metastasis and recurrence and their clinical applications
    Xiangyi Kong, Ran Cheng, Jing Wang, Yi Fang, Kuo Chu Hwang · 2020 · Nano Today
95. siRNA Delivery: From Lipids to Cell‐penetrating Peptides and Their Mimics
    Matt Gooding, Lorcan Browne, Filipa M. Quinteiro, David L. Selwood · 2012 · Chemical Biology & Drug Design
96. N-acetylgalactosamine functionalized mixed micellar nanoparticles for targeted delivery of siRNA to liver
    Hongxia Wang, Menghua Xiong, Yucai Wang, Jing Zhu, Jun Wang · 2012 · Journal of Controlled Release
97. Recent Advances in RNA Therapeutics and RNA Delivery Systems Based on Nanoparticles
    Hojeong Shin, S.D. Park, Yeajee Yim, Jungho Kim, Chulwon Choi, Cheolhee Won, Dal‐Hee Min · 2018 · Advanced Therapeutics
98. Strategies for persistent retention of macromolecules and nanoparticles in the blood circulation
    Yoshinobu Takakura, Yuki Takahashi · 2022 · Journal of Controlled Release
99. Evolution of nanomedicine formulations for targeted delivery and controlled release
    Sanyogitta Puri, Mariarosa Mazza, Gourgopal Roy, R. England, Liping Zhou, Saghar Nourian, J. Anand Subramony · 2023 · Advanced Drug Delivery Reviews
100. Optimized lipid nanoparticles (LNPs) for organ-selective nucleic acids delivery in vivo
     Tian Zhang, Han Yin, Yu Li, Haiyin Yang, Kun Ge, Jinchao Zhang, Qing Yuan, Xuyan Dai, Abid Naeem, Yuhua Weng et al. · 2024 · iScience